Delivery Order SPE2DB22D1202-SPE2DB25FURS5
Award Date
2/4/25
Potential Completion Date
2/5/25
Potential Value
$2.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,163.41, is for the delivery of 4565178934 - NALOXONE 4 MG/10 ML VIAL 10ML. It is a firm fixed-price contract with a completion date of July 18, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,011.01, is for the delivery of 4567422198 - NALOXONE 4 MG/10 ML VIAL 10ML, which is a critical pharmaceutical product. The contract has an ultimate completion date of March 3, 2025 and is a Firm Fixed Price Delivery Order. No set-aside designation was used for this award....
This federal contract award, valued at $1,876.00, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The contract provides for the delivery of 4562819417 ! NALOXONE 2 MG/2 ML SYRINGE 2ML, a critical medical commodity used to...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of NALOXONE 0.4 MG/ML VIALML. The contract has a ceiling value of $2,231.07 and is a firm fixed-price delivery order with a period of performance ending on July 2, 2025. The contract is not set-aside and was awarded on July 1, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,097.84, is for the delivery of 0.4 mg/mL vials of the opioid antagonist drug naloxone. This is a firm fixed-price delivery order contract with a period of performance through March 5, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the...
This is a federal contract award to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, for the supply of 0.4 mg/mL Naloxone vials. The $2,799.99 Firm Fixed Price Delivery Order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency. The contract has a completion date of July 23, 2024 and does not have a set-aside designation. Amerisourcebergen is a significant supplier of pharmaceuticals and medical supplies to various government...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract worth $15,832.80 to AmerisourceBergen Drug Corp's Corporate Office division. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 between DLA and AmerisourceBergen, which serves as the primary vehicle for the company to supply a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide....
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA), a defense agency. The contract is for the delivery of naloxone 0.4 mg/ml vials, a medication used to treat opioid overdose. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,917.14 and a performance period through July 3, 2025. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp also holds a larger...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of naloxone 0.4 mg/ml vials. The contract has a total ceiling value of $1,761.46 and is a firm fixed-price type contract. The period of performance extends through June 21, 2024. This award does not have a set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This federal contract award is to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract, valued at $2,527.15, is for the delivery of Naloxone 2 mg/2 ml syringes to an unspecified location. It is a firm fixed-price delivery order contract with the Defense Logistics Agency (DLA) Troop Support Medical under the agency's primary Indefinite Delivery Contract (IDC) with Amerisourcebergen, valued up...